Latest 8-K filings
OID
LTCH
Latch, INCLatch, Inc. announced its second quarter 2026 financial results, highlighting a 16.8% year-over-year increase in software revenue to $6.1 million, a 12.1% narrowing of its net loss to $(6.9) million, and improved quarterly cash usage.
NASDAQ
Jerash Holdings announced record revenue of $50.2 million and a more than fivefold increase in net income for its fiscal 2027 first quarter, driven by strong demand and improved operational efficiencies.
NASDAQ
Sphere 3D Corp. has implemented a limited-duration shareholder rights plan to ensure fair treatment of all shareholders in the event of a take-over bid.
NASDAQ
AIOT
Powerfleet, INCPowerfleet announced first quarter fiscal 2027 results, highlighting a 9.1% increase in services revenue to $94.3 million and a 79% rise in operating cash flow to $8.4 million, alongside significant acceleration in its South African National Treasury contract.
NASDAQ
CLNN
Clene INCClene Inc. announced new biomarker analyses from its CNM-Au8 trials, showing a correlation between NfL biomarker response and improved survival and function in ALS patients, which will be included in its upcoming NDA submission for accelerated approval.
NASDAQ
QTRX
Quanterix CORPQuanterix reported Q2 2026 revenue of $32.9 million, missing expectations, and revised its full-year revenue guidance downwards, while also extending its cash-flow break-even target to 2027.
NASDAQ
Cogent Biosciences announced strong Q2 2026 financial results, highlighting progress in bezuclastinib development for GIST and Systemic Mastocytosis, with key PDUFA dates approaching and a cash runway extending into late 2028.
NYSE
California Resources Corporation announced robust second quarter 2026 financial and operating results, highlighted by strategic acquisitions, operational efficiencies, and progress in carbon capture initiatives.
NYSE
Archer Aviation Inc. announced a definitive agreement to acquire Boeing's Wisk Aero, SkyGrid, and Insitu subsidiaries, creating a comprehensive AI platform for aerospace and defense, with Boeing taking a strategic stake.
NASDAQ
BYND
Beyond Meat, INCBeyond Meat has entered into a Second Supplemental Indenture to amend its 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030, adjusting debt repurchase restrictions and extending a make-whole period.
NASDAQ
POWW
Ammo, INCOutdoor Holding Company reported a significant turnaround in its fiscal first quarter of 2027, with revenue up 22.1% and a return to profitability, driven by strong marketplace performance and new revenue streams.
NASDAQ
CNDT
Conduent INCConduent Incorporated announced its second quarter 2026 financial results, reporting $531 million in revenue and a net loss, while also detailing progress on its transformation plan and portfolio optimization through divestitures.
NASDAQ
Park Dental Partners, Inc. has entered into a definitive agreement to acquire the dental services organization supporting Village Family Dental, marking its entry into North Carolina.
NYSE
Applied Aerospace & Defense announced the appointment of Chris Rogers to President and Chief Strategy Officer, effective July 27, 2026, to support accelerated growth.
NASDAQ
Evolv Technologies Holdings, Inc. announced the preliminary approval of a settlement for stockholder derivative claims, resolving multiple lawsuits without requiring payment from the company.
Yorkville Acquisition Corp. announced the mutual termination of its business combination agreement with Trump Media & Technology Group Corp. (TMTG) and Crypto.com due to market conditions.
NASDAQ
Telomir Pharmaceuticals announced the publication of peer-reviewed preclinical data demonstrating Telomir-Zn's efficacy in suppressing tumor growth and metastasis in prostate and triple-negative breast cancer models.
NASDAQ
Heron Therapeutics announced Q2 2026 results with mixed revenue performance, withdrew full-year financial guidance, and is exploring strategic alternatives.
NASDAQ
Strategy Inc reported on August 10, 2026, an update on its at-the-market offering, bitcoin sales, and share repurchase programs, highlighting substantial capital raised and a robust USD Reserve.
NYSE
MarineMax, Inc. has entered into a definitive agreement to be acquired by Safe Harbor Marinas, a Blackstone Infrastructure portfolio company, for $53.00 per share in an all-cash transaction valued at approximately $1.5 billion.
NASDAQ
Byrna Technologies Inc. has completed the acquisition of substantially all assets from Hero Defense Systems, LLC, bolstering its less-lethal defense product portfolio.
NASDAQ
Motorcar Parts of America reported a net loss for its fiscal 2027 first quarter, with net sales down year-over-year, but reaffirmed its full-year financial guidance.
NASDAQ
Silence Therapeutics plc reported positive topline results from the Phase 2 SANRECO trial of divesiran for polycythemia vera, meeting primary and secondary endpoints and supporting advancement to Phase 3.
AMEX
INTT
Intest CORPInTest Corporation announced strong second quarter 2026 financial results, with revenue up 25.5% year-over-year to $35.3 million, driven by the Auto/EV market.
NASDAQ
Replimune Group, Inc. announced the pricing of an underwritten offering of common stock and pre-funded warrants, raising approximately $150 million.
NASDAQ
AbCellera Biologics Inc. announced positive top-line results from the Phase 2 portion of its Phase 1/2 clinical trial for ABCL635, showing significant reductions in vasomotor symptoms and a favorable tolerability profile.
NYSE
ATH-PA
Athene Holding LTDAthene Holding Ltd. released its Q2 2026 financial supplement, showcasing robust growth in net invested assets and spread-related earnings, alongside a significant increase in total assets.
NASDAQ
Aeries Technology announced a 43% year-over-year revenue increase to $21.9 million for the quarter ended June 30, 2026, alongside significant improvements in profitability and the launch of its AxAI solution.
NASDAQ
Sharplink, Inc. reported a substantial net loss of $394.3 million for Q2 2026, primarily driven by non-cash unrealized losses and impairments on its Ether holdings, despite a significant increase in total revenue to $11.5 million.
NASDAQ
Jazz Pharmaceuticals announced its definitive agreement to acquire Actio Biosciences for $820 million upfront, plus up to $500 million in contingent consideration, to expand its rare epilepsy portfolio with the addition of ABS-1230.